Selective thrombin inhibitors: The next generation of anticoagulants
- 31 October 1993
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 22 (4), 1089-1092
- https://doi.org/10.1016/0735-1097(93)90420-6
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectorisJournal of the American College of Cardiology, 1993
- Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery diseaseThe American Journal of Cardiology, 1993
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991
- Clinical Pharmacology of Recombinant HirudinPathophysiology of Haemostasis and Thrombosis, 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Development of Recombinant Hirudin as a Therapeutic Anticoagulant and Antithrombotic Agent: Some Objective ConsiderationsSeminars in Thrombosis and Hemostasis, 1989
- Biology of Recombinant Hirudin (CGP 39393): A New Prospect in the Treatment of ThrombosisSeminars in Thrombosis and Hemostasis, 1989
- Antithrombotic Effects of Three Thrombin Inhibitors in a Rat Model of Laser-Induced ThrombosisPathophysiology of Haemostasis and Thrombosis, 1989
- Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty RegistryJournal of the American College of Cardiology, 1988
- Alpha-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells.The Journal of cell biology, 1986